Copper-trafficking efficacy of copper-pyruvaldehyde bis(N 4-methylthiosemicarbazone) on the macular mouse, an animal model of Menkes disease

Pediatric Research

Volumn 72, Issue 3, 2012, Pages 270-276

  Munakata, Mitsutoshi ^a   Kodama, Hiroko ^b   Fujisawa, Chie ^b   Hiroki, Tomoko ^b   Kimura, Kazuhiko ^c   Watanabe, Mika ^a   Nishikawa, Masazumi ^c   Tsuchiya, Shigeru ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MIYAGI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; COPPER COMPLEX; COPPER PYRUVALDEHYDE BIS 4N METHYLTHIOSEMICARBAZONE; CUPRIC CHLORIDE; CYTOCHROME C OXIDASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; DRUG EFFICACY; DRUG TRAFFIC; ELECTROENCEPHALOGRAM; HEMATOLOGY; LIPOPHILICITY; MENKES SYNDROME; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL;

ANIMALS; BETA 2-MICROGLOBULIN; BIOLOGICAL TRANSPORT; COPPER; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX IV; MALE; MENKES KINKY HAIR SYNDROME; MICE; MICE, INBRED C3H; ORGANOMETALLIC COMPOUNDS; THIOSEMICARBAZONES;

EID: 84865332331     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.85     Document Type: Article

References (39)

1. Kodama H, Murata Y. Molecular genetics and pathophysiology of Menkes disease. Pediatr Int 1999;41:430-5. (Pubitemid 29376991)
2. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev 2007;87:1011-46. (Pubitemid 47084675)
3. Kodama H, Fujisawa C. Copper metabolism and inherited copper transport disorders: molecular mechanisms, screening and treatment. Metallomics2009;1:42- 52.
4. Sherwood G, Sarkar B, Kortsak AS. Copper histidinate therapy in Menkes' disease: prevention of progressive neurodegeneration. J Inherit Metab Dis 1989;12:Suppl 2:393-6.
5. Sarkar B, Lingertat-Walsh K, Clarke JT. Copper-histidine therapy for Menkes disease. J Pediatr 1993;123:828-30. (Pubitemid 23316445)
6. Kodama H, Sato E, Gu YH, Shiga K, Fujisawa C, Kozuma T. Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease. J Inherit Metab Dis 2005;28:971-8. (Pubitemid 43168934)
7. Tanaka K, Kobayashi K, Fujita Y, Fukuhara C, Onosaka S, Min K. Effects of chelators on copper therapy of macular mouse, a model animal of Menkes' kinky disease. Res Commun Chem Pathol Pharmacol 1990;69:217-27. (Pubitemid 20272360)
8. Green MA, Klippenstein DL, Tennison JR. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET. J Nucl Med 1988;29: 1549-57.
9. Green MA, Mathias CJ, Welch MJ,et al. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med 1990;31:1989-96.
10. Baerga ID, Maickel RP, Green MA. Subcellular distribution of tissue radiocopper following intravenous administration of 67Cu-labeled Cu- PTSM. Int J Rad Appl Instrum B 1992;19:697-701.
11. Fujibayashi Y, Wada K, Taniuchi H, Yonekura Y, Konishi J, Yokoyama A. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4- methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging. Biol Pharm Bull 1993;16:146-9. (Pubitemid 23129188)
12. Mercer JF. Menkes syndrome and animal models. Am J Clin Nutr 1998;67(5 Suppl):1022S-8S.
13. Yamano T, Shimada M, Kawasaki H, Onaga A, Nishimura M. Clinico- pathological study on macular mutant mouse. Acta Neuropathol 1987;72:256-60. (Pubitemid 17006846)
14. Mori M, Nishimura M. A serine-to-proline mutation in the coppertransporting P-type ATPase gene of the macular mouse. Mamm Genome 1997;8:407-10. (Pubitemid 28067424)
15. Murata Y, Kodama H, Abe T,et al. Mutation analysis and expression of the mottled gene in the macular mouse model of Menkes disease. Pediatr Res 1997;42:436-42. (Pubitemid 27411147)
16. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol 1996;23:957-80. (Pubitemid 27050682)
17. Dearling JL, Lewis JS, Mullen GE, Rae MT, Zweit J, Blower PJ. Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro. Eur J Nucl Med 1998;25:788-92. (Pubitemid 28377043)
18. Taniuchi H, Fujibayashi Y, Okazawa H, Yonekura Y, Konishi J, Yokoyama A. Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET). Biol Pharm Bull 1995;18:1126-9.
19. Minkel DT, Saryan LA, Petering DH. Structure-function correlations in the reaction of bis(thiosemicarbazonato) copper(II) complexes with Ehrlich ascites tumor cells. Cancer Res 1978;38:124-9. (Pubitemid 8253524)
20. Wallhaus TR, Lacy J, Whang J, Green MA, Nickles RJ, Stone CK. Human biodistribution and dosimetry of the PET perfusion agent copper-62- PTSM. J Nucl Med 1998;39:1958-64. (Pubitemid 28518899)
21. Niciu MJ, Ma XM, El Meskini R, Ronnett GV, Mains RE, Eipper BA. Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment. Neuroscience 2006;139: 947-64. (Pubitemid 44308090)
22. Yoshimura N. Histochemical localization of copper in various organs of brindled mice. Pathol Int 1994;44:14-9. (Pubitemid 24072129)
23. Kodama H, Meguro Y, Abe T,et al. Genetic expression of Menkes disease in cultured astrocytes of the macular mouse. J Inherit Metab Dis 1991;14:896-901.
24. Maehara M, Ogasawara N, Mizutani N, Watanabe K, Suzuki S. Cytochrome c oxidase deficiency in Menkes kinky hair disease. Brain Dev 1983;5:533-40. (Pubitemid 14187368)
25. Munakata M, Sakamoto O, Kitamura T,et al. The effects of copperhistidine therapy on brain metabolism in a patient with Menkes disease: a proton magnetic resonance spectroscopic study. Brain Dev 2005;27:297-300. (Pubitemid 40602873)
26. Wong-Riley MT. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 1989;12:94-101. (Pubitemid 19067056)
27. Taniuchi H, Fujibayashi Y, Yonekura Y, Konishi J, Yokoyama A. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia. J Nucl Med 1997;38:1130-4. (Pubitemid 27339625)
28. Wijburg FA, Feller N, Scholte HR, Przyrembel H, Wanders RJ. Studies on the formation of lactate and pyruvate from glucose in cultured skin fibroblasts: implications for detection of respiratory chain defects. Biochem Int 1989;19:563-70. (Pubitemid 19240389)
29. Petering HG, Buskirk HH, Underwood GE. The anti-tumor activity of 2-keto-3-ethoxybutyraldehyde bis(thiosemicarbazone) and related compounds. Cancer Res 1964;24:367-72.
30. Kostyniak PJ, Nakeeb SM, Schopp EM,et al. Acute toxicity and mutagenicity of the copper complex of pyruvaldehyde-bis (N-4- methylthiosemicarbazone), Cu-PTSM. J Appl Toxicol 1990;10:417-21. (Pubitemid 20386401)
31. Ozawa H, Kodama H, Kawaguchi H, Mochizuki T, Kobayashi M, Igarashi T. Renal function in patients with Menkes disease. Eur J Pediatr 2003;162:51-2. (Pubitemid 35478212)
32. Kodama H, Okabe I, Kihara A, Mori Y, Okaniwa M. Renal tubular function of patients with classical Menkes disease. J Inherit Metab Dis 1992;15:157-8.
33. David NA. The pharmacology of dimethyl sulfoxide. Annu Rev Pharmacol 1972;12:353-74.
34. Thomas R. Practical Guide to ICP-MS. New York, NY: Marcel Dekker, 2004; pp. 207-44.
35. Wong-Riley M. Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry.Brain Res 1979;171:11-28. (Pubitemid 9211579)
36. Strazielle C, Kremarik P, Ghersi-Egea JF, Lalonde R. Regional brain variations of cytochrome oxidase activity and motor coordination in Lurcher mutant mice. Exp Brain Res 1998;121:35-45. (Pubitemid 28284661)
37. Franklin KB, Paxinos G. The mouse brain in stereotaxic coordinates. San Diego, California: Academic Press, 1944.
38. Darriet D, Der T, Collins RC. Distribution of cytochrome oxidase in rat brain: studies with diaminobenzidine histochemistry in vitro and [14C]cyanide tissue labeling in vivo. J Cereb Blood Flow Metab 1986;6:8-14. (Pubitemid 16153660)
39. Gonzalez-Lima F, Jones D. Quantitative mapping of cytochrome oxidase activity in the central auditory system of the gerbil: a study with calibrated activity standards and metal-intensified histochemistry. Brain Res 1994;660:34-49. (Pubitemid 24301251)